Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 968 of 1,261

  1. US 7919484

    Combination therapy

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  2. US 7919475

    Compositions and methods for improving heart function

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  3. US 7919473

    IRNA agents targeting VEGF

    Alnylam Pharmaceuticals, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  4. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  5. US 7919246

    SEMA4D in cancer diagnosis, detection and treatment

    Sagres Discovery, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  6. US 7919104

    Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  7. US 7919613

    RNAi modulation of SCAP and therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  8. US 7919079

    Cancer immunotherapy compositions and methods of use

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  9. CA 2760180

    COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES A MEDIATION PAR MCP-1

    ACRAF [IT] · Granted Mar 31, 2011 · Expires Mar 26, 2031

    granted

  10. US 7915267

    Heterocyclic amide compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  11. US 7914780

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  12. US 7914788

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  13. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  14. US 7915040

    Defensin-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  15. US 7915305

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  16. US 7914801

    Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  17. US 7915025

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  18. US 7914990

    Methods and products for in vitro genotyping

    PROGENIKA BIOPHARMA, S.A. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  19. US 7915245

    Methods and compositions of trail-death receptor agonists/activators

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  20. US 7915215

    Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof

    Appleton Papers Inc. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  21. US 7915240

    Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

    OM PHARMA · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  22. US 7915273

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  23. US 7915396

    Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  24. US 7915385

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.